Can sacubitril/valsartan become the promising drug to delay the progression of chronic kidney disease?

Yang Chen; Lu-Ying Guo; Ling-Fei Zhao; Yan-Hong Ma; Xue-Ling Zhu; Ying Xu; Jiang-Hua Chen

doi:10.11909/j.issn.1671-5411.2020.12.002

Can sacubitril/valsartan become the promising drug to delay the progression of chronic kidney disease?

J Geriatr Cardiol. 2020 Dec 28;17(12):782-786. doi: 10.11909/j.issn.1671-5411.2020.12.002.

Authors

Yang Chen^{1

2

3

4}, Lu-Ying Guo^{1

2

3

4}, Ling-Fei Zhao^{1

2

3

4}, Yan-Hong Ma^{1

2

3

4}, Xue-Ling Zhu^{5

6

7}, Ying Xu^{1

2

3

4

1}, Jiang-Hua Chen^{1

2

3

4}

Affiliations

¹ Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, China.
² The Third Grade Laboratory under the National State, Administration of Traditional Chinese Medicine, Zhejiang, China.
³ Key Laboratory of Kidney Disease Prevention and Control Technology, Zhejiang, China.
⁴ National Key Clinical Department of Kidney Diseases, Institute of Nephrology, Zhejiang University, Zhejiang, China.
⁵ State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang, China.
⁶ National Clinical Research Center for Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, China.
⁷ Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, China.

PMID: 33424946
PMCID: PMC7762693
DOI: 10.11909/j.issn.1671-5411.2020.12.002

No abstract available

Keywords: Cardiovascular disease; Chronic kidney disease; Kidney function; Sacubitril/valsartan.